204 episodes
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education cancerGRACE
-
- Health & Fitness
In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership.
We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis.
For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums
-
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma
Dr. Tycel Phillips examines the efficacy of two medications against diffuse large b-cell lymphoma (DLBCL)
-
Barriers to Biomarker Testing: Cost and Insurance
Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.
-
Barriers to Biomarker Testing: Ordering Tests
Dr. Aakash Desai emphasizes the importance of physicians ordering biomarker testing for patients with NSCLC
-
The Adaura Trial: The Effect on EGFR+ Treatment
Dr. Joshua Reuss discusses the ADAURA trial, which suggested Osimertinib as treatment for EGFR+ NSCLC.
-
Biomarker Driven Therapy for NSCLC
Dr. Aakash Desai discusses the administration of therapy for biomarkers, and how to overcome the gaps in administration, access, and affordability.
-
Current Recommendations and Best Practices for Biomarker Testing
Dr. Aakash Desai discusses the current recommendations for biomarker testing in patients with NSCLC, as well as best practices.